Skip to main content
. 2023 Sep 27;28:379. doi: 10.1186/s40001-023-01317-x

Table 1.

Demographics of the 72-h URVNA and URVA patients

Age ≤ 50 50 ~ 60 p value 60 ~ 70 p value 70 ~ 80 p value Age ≥ 80
URVNA URVA p value URVNA URVA URVNA URVA URVNA URVA URVNA URVA p value
n 2221 554 1020 402 1349 727 968 599 708 935
Sex (%)
 Male 998 (44.93) 259 (46.75) 0.47 573 (56.21) 255 (63.4) 0.01 648 (48.02) 397 (54.61)  < 0.001 465 (48.07) 354 (59.12)  < 0.001 368 (51.97) 457 (48.88) 0.23
 Female 1223 (55.07) 295 (53.25) 0.47 447 (43.89) 147 (36.6) 0.01 701 (52.98) 330 (45.39) 0.004 503 (51.93) 245 (40.88)  < 0.001 340 (48.03) 478 (51.12) 0.23
 Length of stay 4.33 (6.07) 6.63 (8.31)  < 0.001 5.43 (7.92) 7.76 (10.01)  < 0.001 5.57 (7.30) 7.93 (8.54)  < 0.001 6.46 (8.11) 8.26 (8.80)  < 0.001 9.12 (9.19) 6.27 (7.37)  < 0.001
Triage (%)
 Severe 217 (9.77) 117 (21.12)  < 0.001 151 (14.80) 108 (26.87)  < 0.001 217 (16.09) 239 (32.87)  < 0.001 190 (19.63) 203 (33.89)  < 0.001 176 (18.82) 287 (40.54) 0.01
 Non-severe 2004 (90.23) 437 (78.88)  < 0.001 869 (85.20) 294 (73.13)  < 0.001 1132 (83.91) 488 (67.13)  < 0.001 778 (80.37) 396 (66.11)  < 0.001 532 (81.18) 748 (59.46) 0.02
Vital Sign (mean (SD))
 Temp 37.02 (2.31) 37.22 (1.95) 0.04 36.78 (1.85) 36.99 (2.15) 0.08 36.75 (1.66) 37.02 (2.27) 0.01 36.70 (1.85) 37.13 (1.92)  < 0.001 36.77 (1.43) 37.11 (0.96)  < 0.001
 Breath 19.12 (3.13) 19.50 (4.07) 0.04 19.05 (2.32) 19.41 (3.25) 0.04 19.13 (2.29) 19.91 (4.25)  < 0.001 19.21 (2.55) 19.75 (3.06)  < 0.001 19.49 (3.53) 20.48 (4.51)  < 0.001
 SBP 132.46 (22.87) 129.92 (23.81) 0.02 143.75 (27.32) 138.25 (27.94)  < 0.001 146.64 (28.23) 139.80 (30.99)  < 0.001 148.42 (29.57) 139.10 (27.73)  < 0.001 146.45 (30.43) 141.65 (30.67) 0.001
 DBP 85.29 (16.22) 82.89 (17.29) 0.003 89.66 (17.38) 86.39 (17.52) 0.001 87.30 (16.54) 83.91 (20.94)  < 0.001 83.53 (16.66) 78.59 (16.89)  < 0.001 77.46 (17.25) 76.72 (17.60) 0.40
 Pulse 95.78 (20.66) 100.98 (21.78)  < 0.001 92.01 (19.41) 97.88 (22.38)  < 0.001 90.27 (19.63) 97.36 (23.42)  < 0.001 87.23 (18.05) 92.25 (21.48)  < 0.001 85.28 (18.83) 88.86 (21.18)  < 0.001
Index Score (mean (SD))
 RAPS 2.33 (1.45) 2.53 (1.56)  < 0.001 2.69 (1.53) 2.77 (1.65) 0.39 2.60 (1.53) 2.83 (1.83) 0.003 2.54 (1.52) 2.55 (1.65) 0.78 2.41 (1.60) 2.69 (1.74)  < 0.001
 qSOFA 1.09 (0.32) 1.17 (0.42)  < 0.001 1.11 (0.33) 1.20 (0.47)  < 0.001 1.11 (0.34) 1.24 (0.52)  < 0.001 1.14 (0.39) 1.28 (0.51)  < 0.001 1.20 (0.45) 1.41 (0.63)  < 0.001
 CCI 1.22 (0.64) 1.59 (1.00)  < 0.001 2.74 (1.15) 3.36 (1.35)  < 0.001 4.09 (1.32) 4.64 (1.45)  < 0.001 5.35 (1.36) 5.77 (1.43)  < 0.001 6.47 (1.49) 6.79 (1.59)  < 0.001
 GCS 14.87 (1.10) 14.80 (1.24) 0.22 14.87 (0.95) 14.76 (1.27) 0.13 14.88 (0.84) 14.72 (1.37) 0.003 14.81 (1.16) 14.68 (1.32) 0.06 14.75 (1.12) 14.29 (1.90)  < 0.001
 Shock Index (HR/SBP) 0.74 (0.18) 0.80 (0.21)  < 0.001 0.66 (0.18) 0.74 (0.23)  < 0.001 0.64 (0.19) 0.73 (0.24)  < 0.001 0.61 (0.18) 0.68 (0.20)  < 0.001 0.61 (0.19) 0.65 (0.21)  < 0.001
Comorbidity (%)
 MI 2 (0.09) 3 (0.54) 0.09 4 (0.39) 10 (2.49)  < 0.001 8 (0.59) 16 (2.20) 0.002 5 (0.52) 16 (2.67)  < 0.001 7 (0.75) 14 (1.98) 0.49
 CHF 14 (0.63) 16 (2.89)  < 0.001 14 (1.37) 11 (2.74) 0.12 44 (3.26) 45 (6.19) 0.002 54 (5.58) 51 (8.51) 0.03 70 (7.49) 97 (13.70) 0.81
 PVD 2 (0.09) 0 (0.00) NA 1 (0.10) 1 (0.25) NA 4 (0.30) 4 (0.55) 0.60 0 (0.00) 3 (0.50) NA 4 (0.43) 5 (0.71) 1.00
 CVA 10 (0.45) 5 (0.90) 0.33 18 (1.76) 11 (2.74) 0.34 37 (2.74) 32 (4.40) 0.06 42 (4.34) 48 (8.01) 0.003 85 (9.09) 66 (9.32)  < 0.001
 Dementia 0 (0.00) 0 (0.00) NA 0 (0.00) 0 (0.00) NA 3 (0.22) 0 (0.00) NA 6 (0.62) 8 (1.34) 0.24 34 (3.64) 39 (5.51) 0.62
 COPD 6 (0.27) 1 (0.18) NA 12 (1.18) 5 (1.24) 1.00 30 (2.22) 31 (4.26) 0.01 38 (3.93) 31 (5.18) 0.30 42 (4.49) 54 (7.63) 0.98
 CTD 20 (0.90) 27 (4.87)  < 0.001 6 (0.59) 1 (0.25) NA 13 (0.96) 15 (2.06) 0.06 13 (1.34) 5 (0.83) 0.50 6 (0.64) 12 (1.69) 0.55
 PUD 27 (1.22) 3 (0.54) 0.25 16 (1.57) 14 (3.48) 0.04 49 (3.63) 23 (3.16) 0.67 24 (2.48) 19 (3.17) 0.51 20 (2.14) 27 (3.81) 1.00
 Liver disease 24 (1.08) 20 (3.61)  < 0.001 40 (3.92) 30 (7.46) 0.008 66 (4.89) 53 (7.29) 0.03 44 (4.55) 32 (5.34) 0.55 22 (2.35) 26 (3.67) 0.81
 DM 113 (5.09) 38 (6.86) 0.12 127 (12.45) 87 (21.64)  < 0.001 282 (20.90) 227 (31.22)  < 0.001 301 (31.10) 238 (39.73)  < 0.001 273 (29.20) 259 (36.58)  < 0.001
 CKD 24 (1.08) 12 (2.17) 0.07 49 (4.80) 24 (5.97) 0.44 88 (6.52) 75 (10.32) 0.003 121 (12.50) 97 (16.19) 0.05 199 (21.28) 158 (22.32)  < 0.001
 Tumor 75 (3.38) 66 (11.91)  < 0.001 168 (16.47) 132 (32.84)  < 0.001 306 (22.68) 243 (33.43)  < 0.001 223 (23.04) 171 (28.55) 0.02 183 (19.57) 147 (20.76)  < 0.001
 Leukemia 7 (0.32) 5 (0.90) 0.13 0 (0.00) 2 (0.50) NA 0 (0.00) 4 (0.55) NA 1 (0.10) 2 (0.33) 0.67 0 (0.00) 2 (0.28) NA
 Lymphoma 2 (0.09) 0 (0.00) NA 5 (0.49) 4 (1.00) 0.48 6 (0.44) 2 (0.28) 0.82 1 (0.10) 4 (0.67) 0.14 1 (0.11) 6 (0.85) 0.25
 AIDS 14 (0.63) 15 (2.71)  < 0.001 2 (0.20) 0 (0.00) NA 2 (0.15) 1 (0.14) 1.00 2 (0.21) 2 (0.33) 1.00 0 (0.00) 0 (0.00) NA

Temp temperature, SBP systolic blood pressure, DBP diastolic blood pressure, RAPS Rapid Acute Physiology Score, qSOFA Sequential Organ Failure Assessment, CCI Charlson Comorbidity Index, PVD peripheral artery disease, GCS Glasgow Coma Scale, MI myocardial infarction, CHF congestive heart failure, PVD peripheral vascular disease, CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease, CTD connective tissue disease, PUD peptic ulcer disease, DM diabetes mellitus, CKD chronic kidney disease, AIDS acquired immunodeficiency syndrome